Table of contents


Top

Focus

Focus on Antivirals

This issue provides several articles focusing on antiviral therapy. Additional material, brought together in a joint focus with Nature Reviews Drug Discovery supported by our principal sponsor Pfizer and our supporting sponsor Gilead, is also available by clicking on the link to “Joint Focus” above.

Top

News

Pfizer dumps Exubera pp1331 - 1332

George S. Mack

doi:10.1038/nbt1207-1331


Proposed changes to patent code loom over biotech industry pp1333 - 1334

Amy Coombs

doi:10.1038/nbt1207-1333


Biogen Idec goes on the auction block pp1335 - 1336

Randall Osborne

doi:10.1038/nbt1207-1335


Chinese manufacturers vie for piece of outsourcing pie pp1337 - 1338

Hepeng Jia

doi:10.1038/nbt1207-1337


In Brief

News in brief pp1339 - 1340

doi:10.1038/nbt1207-1339


Data Pages

Biotech patents still strong p1341

Stacy Lawrence

doi:10.1038/nbt1207-1341


Pipelines turn to biotech p1342

Stacy Lawrence

doi:10.1038/nbt1207-1342


News Feature

Biotech for your companion? pp1343 - 1345

Jim Kling

doi:10.1038/nbt1207-1343


Top

Bioentrepreneur

Building a business

Best practices in patent license negotiations pp1347 - 1349

Jennifer Giordano-Coltart & Charles W Calkins

doi:10.1038/bioe.2007.5


Top

Opinion and Comment

Correspondence

GM soybeans—revisiting a controversial format pp1351 - 1354

Irina V. Ermakova

doi:10.1038/nbt1207-1351


GM soybeans—revisiting a controversial format pp1354 - 1355

Brian John

doi:10.1038/nbt1207-1354


GM soybeans—revisiting a controversial format p1355

Mae-Wan Ho & Peter T Saunders

doi:10.1038/nbt1207-1355a


GM soybeans—revisiting a controversial format p1355

Carlo Leifert

doi:10.1038/nbt1207-1355b


GM soybeans—revisiting a controversial format pp1355 - 1356

Jack A Heinemann & Terje Traavik

doi:10.1038/nbt1207-1355c


GM soybeans—revisiting a controversial format p1356

Joe Cummins

doi:10.1038/nbt1207-1356a


Response to GM soybeans—revisiting a controversial format pp1356 - 1358

doi:10.1038/nbt1207-1356b



Commentary

Top

News and Views

Fungal bioinsecticide with a sting pp1367 - 1368

Matthew B Thomas & Andrew F Read

doi:10.1038/nbt1207-1367

See also: Research by Wang & St Leger



Research highlights p1373

doi:10.1038/nbt1207-1373


Top

Editorial

Antivirals

Beyond interferon p1375

doi:10.1038/nbt1207-1375


Top

News

Profile

Antivirals

Ian Frazer p1377

Mark Ratner

doi:10.1038/nbt1207-1377


News Feature

Antivirals

Hepatitis C: staying the course pp1379 - 1381

Ken Garber

doi:10.1038/nbt1207-1379


Top

Opinion and Comment

Commentary

Antivirals

Systems biology and the host response to viral infection pp1383 - 1389

Seng-Lai Tan, Gopinath Ganji, Bryan Paeper, Sean Proll & Michael G Katze

doi:10.1038/nbt1207-1383


Antivirals

Antivirals—an increasingly healthy investment pp1390 - 1393

Brian McCarthy

doi:10.1038/nbt1207-1390


Top

Feature

Antivirals

Antivirals become a broader enterprise pp1395 - 1402

Jeffrey L Fox

doi:10.1038/nbt1207-1395


Patents

Antivirals

Patentability issues surrounding antivirals pp1403 - 1404

Deborah L Lu, Angela M Collison & Thomas J Kowalski

doi:10.1038/nbt1207-1403


Antivirals

Recent patent applications in antivirals p1405

doi:10.1038/nbt1207-1405


Top

Computational Biology

Commentary

Antivirals

Bioinformatics prediction of HIV coreceptor usage pp1407 - 1410

Thomas Lengauer, Oliver Sander, Saleta Sierra, Alexander Thielen & Rolf Kaiser

doi:10.1038/nbt1371


Top

Research

Perspective

Antivirals

Albinterferon α-2b: a genetic fusion protein for the treatment of chronic hepatitis C pp1411 - 1419

G Mani Subramanian, Michele Fiscella, Araba Lamousé-Smith, Stefan Zeuzem & John G McHutchison

doi:10.1038/nbt1364


Reviews


Antivirals

RNA interference against viruses: strike and counterstrike pp1435 - 1443

Joost Haasnoot, Ellen M Westerhout & Ben Berkhout

doi:10.1038/nbt1369


Antivirals

Genetic therapies against HIV pp1444 - 1454

John J Rossi, Carl H June & Donald B Kohn

doi:10.1038/nbt1367


Brief Communication

Articles

Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state pp1457 - 1467

Brian D Brown, Bernhard Gentner, Alessio Cantore, Silvia Colleoni, Mario Amendola, Anna Zingale, Alessia Baccarini, Giovanna Lazzari, Cesare Galli & Luigi Naldini

doi:10.1038/nbt1372


Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells pp1468 - 1475

Gabsang Lee, Hyesoo Kim, Yechiel Elkabetz, George Al Shamy, Georgia Panagiotakos, Tiziano Barberi, Viviane Tabar & Lorenz Studer

doi:10.1038/nbt1365


Letters

Identification and targeting of the ROSA26 locus in human embryonic stem cells pp1477 - 1482

Stefan Irion, Hervé Luche, Paul Gadue, Hans Joerg Fehling, Marion Kennedy & Gordon Keller

doi:10.1038/nbt1362


Redirecting lipoic acid ligase for cell surface protein labeling with small-molecule probes pp1483 - 1487

Marta Fernández-Suárez, Hemanta Baruah, Laura Martínez-Hernández, Kathleen T Xie, Jeremy M Baskin, Carolyn R Bertozzi & Alice Y Ting

doi:10.1038/nbt1355


Errata

Erratum: Funding crunch forces stem cell company to abandon therapies p1488

Monya Baker

doi:10.1038/nbt1207-1488a


Erratum: Mice with a human touch p1488

Christopher Thomas Scott

doi:10.1038/nbt1207-1488b


Erratum: Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria p1488

Russell P Rother, Scott A Rollins, Christopher F Mojcik, Robert A Brodsky & Leonard Bell

doi:10.1038/nbt1207-1488c


Corrigenda

Corrigendum: A diverse family of thermostable cytochrome P450s created by recombination of stabilizing fragments p1488

Yougen Li, D Allan Drummond, Andrew M Sawayama, Christopher D Snow, Jesse D Bloom & Frances H Arnold

doi:10.1038/nbt1207-1488d


Top

Naturejobs

Careers and Recruitment

Management consulting for scientists pp1489 - 1490

Samarth Kulkarni

doi:10.1038/nbt1207-1489


People

People p1492

doi:10.1038/nbt1207-1492


Top

Extra navigation

Subscribe to Nature Biotechnology

Subscribe

naturejobs

natureproducts


ADVERTISEMENT